Cardinal Health Inc (NYSE:CAH) Stock Price While Sentiment Dive

April 25, 2018 - By Adrian Erickson

Cardinal Health, Inc. (NYSE:CAH) Logo

Sentiment for Cardinal Health Inc (NYSE:CAH)

Cardinal Health Inc (NYSE:CAH) institutional sentiment decreased to 0.75 in Q4 2017. Its down -0.15, from 0.9 in 2017Q3. The ratio has dropped, as 238 hedge funds started new or increased positions, while 318 sold and trimmed positions in Cardinal Health Inc. The hedge funds in our partner’s database reported: 276.20 million shares, up from 275.05 million shares in 2017Q3. Also, the number of hedge funds holding Cardinal Health Inc in their top 10 positions decreased from 5 to 4 for a decrease of 1. Sold All: 82 Reduced: 236 Increased: 173 New Position: 65.

Cardinal Health, Inc. operates as an integrated healthcare services and products firm worldwide. The company has market cap of $20.00 billion. The companyÂ’s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It has a 11.08 P/E ratio. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers.

The stock increased 1.93% or $1.205 during the last trading session, reaching $63.565. About 2.43 million shares traded. Cardinal Health, Inc. (NYSE:CAH) has declined 25.57% since April 25, 2017 and is downtrending. It has underperformed by 37.12% the S&P500.

Analysts await Cardinal Health, Inc. (NYSE:CAH) to report earnings on May, 3 before the open. They expect $1.51 EPS, down 1.31 % or $0.02 from last year’s $1.53 per share. CAH’s profit will be $475.20 million for 10.52 P/E if the $1.51 EPS becomes a reality. After $1.31 actual EPS reported by Cardinal Health, Inc. for the previous quarter, Wall Street now forecasts 15.27 % EPS growth.

Healthinvest Partners Ab holds 5.9% of its portfolio in Cardinal Health, Inc. for 45,600 shares. Mcdonald Capital Investors Inc Ca owns 715,615 shares or 3.5% of their US portfolio. Moreover, Rr Partners Lp has 3.14% invested in the company for 770,100 shares. The Massachusetts-based Baupost Group Llc Ma has invested 3.09% in the stock. Kempner Capital Management Inc., a Texas-based fund reported 69,392 shares.

Since January 1, 0001, it had 0 insider buys, and 3 insider sales for $3.82 million activity.

Cardinal Health, Inc. (NYSE:CAH) Ratings Coverage

Ratings analysis reveals 18% of Cardinal Health’s analysts are positive. Out of 11 Wall Street analysts rating Cardinal Health, 2 give it “Buy”, 2 “Sell” rating, while 7 recommend “Hold”. The lowest target is $64 while the high is $8500. The stock’s average target of $73.44 is 15.54% above today’s ($63.565) share price. CAH was included in 14 notes of analysts from November 7, 2017. Argus Research upgraded the shares of CAH in report on Monday, April 2 to “Buy” rating. The stock of Cardinal Health, Inc. (NYSE:CAH) earned “Hold” rating by Jefferies on Tuesday, November 7. The stock has “Outperform” rating by Leerink Swann on Tuesday, April 24. On Monday, April 16 the stock rating was maintained by Barclays Capital with “Equal-Weight”. Jefferies maintained Cardinal Health, Inc. (NYSE:CAH) on Friday, February 9 with “Hold” rating. Mizuho maintained the stock with “Hold” rating in Wednesday, January 24 report. The rating was maintained by RBC Capital Markets on Thursday, February 8 with “Hold”. The rating was downgraded by Argus Research on Wednesday, November 15 to “Hold”. The firm has “Underweight” rating given on Monday, November 20 by Morgan Stanley. The rating was maintained by Robert W. Baird on Wednesday, January 17 with “Hold”.

Cardinal Health, Inc. (NYSE:CAH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: